F5 and plasma cell myeloma: In one study, individuals with lymphoma or multiple myeloma who carried factor V Leiden and SERPINA10 variants had higher VTE incidence; other data indicate that the coexistence of cancer and factor V Leiden variants synergistically increases VTE risk (Gran et al., 2016).